Biotech Startups

TKG develops advanced nucleic acid therapeutics and synthesis technologies for medical applications. The company focuses on applying nucleic acid medicine to address healthcare challenges globally.

1 investor

1 investor

1 investor

TOLREMO therapeutics develops small molecule inhibitors targeting transcriptional resistance mechanisms in cancer, with a lead clinical candidate TT125-802 designed for solid tumors and hematological malignancies as both monotherapy and combination treatment.

1 investor

Tomorrow Taste develops plant-based sweetener technology and beverages, creating protein-derived sweeteners for food and beverage manufacturers. The company serves brands seeking alternative sweetening solutions for consumer products.

1 investor

Topaz Therapeutics is developing a platform of next-generation oncology drugs.

1 investor

Topos Bio develops an AI-native drug discovery platform focused on intrinsically disordered proteins, which are dynamic proteins associated with diseases such as Alzheimer's and prostate cancer. Its approach models protein ensembles instead of single static structures to target proteins previously considered undruggable.

1 investor

Toralgen is a preclinical biopharmaceutical company developing oral drug delivery treatments for diabetes and autoimmune disorders using a poly-bile nanoparticle platform technology licensed from Yale University research.

1 investor

1 investor

Clinical-stage biotechnology company developing novel antibody-based therapies to transform cancer treatment.

1 investor

Torpedo Therapeutics develops high-precision, closed-loop deep brain stimulation devices for treating neurological disorders including Parkinson's disease, essential tremor, dystonia, and drug-resistant epilepsy. The company uses micro- and nano-fabrication to create ultra-small electrode leads with machine learning-driven parameter adjustment to reduce side effects and improve treatment efficacy.

1 investor

Totus Medicines is a biopharmaceutical company developing small molecule drugs to address untreatable diseases by combining approaches in molecular design, structural biology, genetics, and cell biology. The company focuses on oncology and other therapeutic areas for patients with currently incurable conditions.

1 investor

Touchlight manufactures enzymatic DNA for genetic medicine applications, including mRNA and DNA vaccines, viral vector production, gene therapy, and genome editing. The company operates GMP-compliant manufacturing suites using cell-free DNA technology to produce pharmaceutical-grade plasmid DNA at commercial scale.

1 investor

Toxometris provides AI-powered in silico toxicity predictions for pharmaceutical compounds, combining mechanistic interpretability with predictive accuracy. The platform serves medicinal chemists and toxicologists for lead optimization, regulatory submission support, and compound library screening.

1 investor

ToxoTech is a biopharmaceutical company developing therapies for neurological disorders. It has announced a strategic collaboration with AAX Biotech to advance next-generation biotherapeutics.

1 investor

TPS is a global clinical research solutions company focused on study execution, connecting sponsors, sites, and patients to accelerate enrollment, improve retention, and assure data integrity. It positions itself as distinct from CROs and staffing agencies, offering services to convert sponsor spend into measurable trial outcomes.

1 investor

TQ Therapeutics develops cell and gene therapy technologies and processes to make challenging diseases curable. The company focuses on manufacturing and engineering advances in cell therapy for patient treatment.

1 investor

Traceless manufactures thermoplastic natural polymer-based materials that serve as plastic substitutes, operating the world's first industrial-scale production facility for these materials. The company serves manufacturers and brands seeking circular, biodegradable alternatives to conventional plastics.

1 investor

TRACER offers customized data quality services and analysis, emphasizing precision and speed to support faster decision-making for clients.

1 investor

Tracer Biotechnologies develops genomic profiling and biomarker detection solutions for oncology and cancer treatment. The company serves healthcare providers and clinical laboratories focused on precision medicine and treatment guidance.

1 investor

Tradewind BioScience translates research discoveries into novel cancer therapeutics. The company develops drug therapies for cancer patients through research-driven drug discovery and development.

1 investor

Trailhead Biosystems develops HD-DoE (High-Dimensional Design-of-Experiments), a platform that uses computational models and control systems to differentiate human induced pluripotent stem cells (iPSCs) into specific cell types for regenerative medicine and stem cell research. The company serves stem cell researchers and cell-therapy developers with iPSC research products and differentiation technologies.

1 investor

TraitSeq provides a computational platform that integrates omics data, machine learning, and AI to help agricultural R&D teams translate field performance variations into mechanistic insights, accelerating the development of biological products. The platform serves bioinformatics, R&D, product, and leadership teams working on crop and plant optimization.

1 investor

Strateos operates a cloud lab platform offering laboratory automation-as-a-service, using high-throughput robotics that let scientists design, run, and analyze experiments remotely via a web browser. It serves pharmaceutical companies, biotechs, startups, academia, CROs, and AI drug discovery teams in the life sciences.

1 investor